ZNF148 and anemia: Loss of one copy of Zfp148 markedly reduced tumor frequency in the APCMin/+ model of colorectal carcinoma, extended survival of the mice with 69%, and reduced secondary manifestations of the disease including anaemia and intestinal bleedings.